Literature DB >> 8619107

Effect of non-random missing data mechanisms in clinical trials.

S C Choi1, I L Lu.   

Abstract

A simple form of non-ignorable missing data mechanisms based on two parameters is used to characterize the amount of missing data and the severity of non-randomness in clinical trials. Based on the formulation, the effect of non-randomly missing data on simple analyses which ignore the missing data is studied for binary and normally distributed response variables. In general, the effect of the non-randomly missing data on the bias and the power increases with the severity of non-randomness. The bias can be positive or negative and the power can be less than or greater than when the data are missing at random. The results of the analysis, ignoring the missing data, can be seriously flawed if the non-randomness is severe, even when only a small proportion of the sample is missing. The problem is more pronounced in the case of normally distributed response variables with unequal variances.

Entities:  

Mesh:

Year:  1995        PMID: 8619107     DOI: 10.1002/sim.4780142407

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  3 in total

Review 1.  What is meant by intention to treat analysis? Survey of published randomised controlled trials.

Authors:  S Hollis; F Campbell
Journal:  BMJ       Date:  1999-09-11

2.  A randomized trial of the addition of home-based exercise to specialist heart failure nurse care: the Birmingham Rehabilitation Uptake Maximisation study for patients with Congestive Heart Failure (BRUM-CHF) study.

Authors:  Kate Jolly; Rod S Taylor; Gregory Y H Lip; Mick Davies; Russell Davis; Jonathan Mant; Sally Singh; Sheila Greenfield; Jackie Ingram; Jane Stubley; Stirling Bryan; Andrew Stevens
Journal:  Eur J Heart Fail       Date:  2009-02       Impact factor: 15.534

3.  Guided self-help concreteness training as an intervention for major depression in primary care: a Phase II randomized controlled trial.

Authors:  E R Watkins; R S Taylor; R Byng; C Baeyens; R Read; K Pearson; L Watson
Journal:  Psychol Med       Date:  2011-11-16       Impact factor: 7.723

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.